Which agent is most appropriate for Pneumocystis jirovecii pneumonia prophylaxis in HIV infection?

Study for the PANCE Infectious Disease Test. Dive into flashcards and multiple choice questions, each equipped with hints and detailed explanations. Prepare thoroughly for your exam!

Multiple Choice

Which agent is most appropriate for Pneumocystis jirovecii pneumonia prophylaxis in HIV infection?

Explanation:
TMP-SMX is the best choice for Pneumocystis jirovecii pneumonia prevention in HIV because it provides highly effective protection against PCP and also reduces the risk of toxoplasmosis, a common co-infection in this population. It’s the standard first-line prophylaxis due to its proven efficacy, broad protective benefits, wide availability, and cost-effectiveness. Prophylaxis is typically indicated when the CD4 count falls below 200 cells/µL or there is oropharyngeal candidiasis. Alternatives like dapsone, atovaquone, or inhaled/IV pentamidine exist for those who cannot take TMP-SMX, but they are less effective, more limited in coverage, or carry greater toxicity risks.

TMP-SMX is the best choice for Pneumocystis jirovecii pneumonia prevention in HIV because it provides highly effective protection against PCP and also reduces the risk of toxoplasmosis, a common co-infection in this population. It’s the standard first-line prophylaxis due to its proven efficacy, broad protective benefits, wide availability, and cost-effectiveness. Prophylaxis is typically indicated when the CD4 count falls below 200 cells/µL or there is oropharyngeal candidiasis. Alternatives like dapsone, atovaquone, or inhaled/IV pentamidine exist for those who cannot take TMP-SMX, but they are less effective, more limited in coverage, or carry greater toxicity risks.

More practice questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy